Sonic Hedgehog-Gli1 signaling pathway might become an effective therapeutic target in gastrointestinal neuroendocrine

Takashi Shida1, Mitsuko Furuya, Takashi Nikaido

  • 1Departments of Molecular Pathology, General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.

Cancer Biology & Therapy
|November 15, 2006
PubMed

Insights

Hedgehog (Hh) signaling is upregulated in aggressive gastrointestinal neuroendocrine carcinomas (NECs). Targeting this pathway with cyclopamine suppressed NEC growth and invasion, suggesting a new therapeutic strategy.

Area of Science:

  • Oncology
  • Gastroenterology
  • Molecular Biology

Background:

  • Gastrointestinal neuroendocrine carcinomas (NECs) are highly aggressive with poor prognosis.
  • Aberrant expression of human achaete-scute homologue gene 1 (hASH1) is observed in NECs.
  • Notch, Wnt, and Hedgehog (Hh) signaling pathways are implicated in gastrointestinal stem cell self-renewal and carcinogenesis.

Purpose of the Study:

  • To investigate the role of Hedgehog (Hh) signaling in the pathophysiology of gastrointestinal NECs.
  • To evaluate the therapeutic potential of targeting Hh signaling in NECs.

Main Methods:

  • Quantitative real-time RT-PCR and immunohistochemistry to assess Gli1 expression in NECs, carcinoid tumors, adenocarcinomas, and normal mucosa.
  • In vitro studies using NEC cell lines treated with cyclopamine, a Hh signaling inhibitor.
  • Analysis of cell proliferation, invasion, apoptosis, and gene expression changes (Gli1, Ptch1, Snail, hASH1, E-cadherin) following cyclopamine treatment.

Main Results:

  • Hedgehog (Hh) signaling, indicated by Gli1 expression, was significantly upregulated in NECs compared to adenocarcinomas and normal tissues.
  • Cyclopamine treatment suppressed NEC cell proliferation and invasion, and induced apoptosis in vitro.
  • Cyclopamine treatment led to downregulation of Gli1, Ptch1, Snail, and hASH1, and upregulation of E-cadherin in NEC cells.

Conclusions:

  • Hedgehog (Hh) signaling plays a critical role in the development and progression of gastrointestinal NECs.
  • Inhibition of Hh signaling via cyclopamine demonstrates therapeutic efficacy by reducing tumor viability and altering tumor cell characteristics.
  • Targeting the Hh pathway with cyclopamine or its derivatives represents a promising therapeutic strategy for NECs.

Related Concept Videos

Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...